Navigation Links
Labopharm Reports Results for First Quarter Fiscal 2008
Date:5/8/2008

--------

Net change in non-cash operating items 930 1,168

-------------------------------------------------------------------------

(6,794) (3,250)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

INVESTING ACTIVITIES

-------------------------------------------------------------------------

Acquisition of marketable securities (23,553) (43,023)

-------------------------------------------------------------------------

Proceeds from maturities of marketable securities 34,061 61,414

-------------------------------------------------------------------------

Acquisition of restricted long-term investment (45) -

-------------------------------------------------------------------------

Acquisition of property, plant and equipment (519) (820)

-------------------------------------------------------------------------

Acquisition of intangible assets (98) (74)

-------------------------------------------------------------------------

9,846 17,497

-------------------------------------------------------------------------

-------------------------------------------------------------------------

FINANCING ACTIVITIES

-------------------------------------------------------------------------

Repayment of capital lease obligations (25) (22)

-------------------------------------------------------------------------

Repayment of long-term debt - (1,043)

-------------------------------------------------------------------------

Proceeds from
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...targeted information, study finds , , FR... almost six times more likely than white women to ...r choice of breast cancer treatment, a new report ...an Comprehensive Cancer Center found that despite ...ng the treatment plan, Latinas were more likely to...
(Date:11/22/2008)...elves from stroke, heart attack, , , FR...cine,s mantras: If you have high blood pressure, t...t on your risk of stroke, heart disease and more. ...sure still aren,t doing a good enough job controll...ntrol and Prevention study. , "High blood pres...
(Date:11/22/2008)...x without losing taste, experts say , , ...healthier this holiday season by altering recipes ... Texas AgriLife Extension Service. , Holiday c...almost any holiday recipe without a noticeable dif...owicz said in a news release. , "If a recipe c...
(Date:11/22/2008)... now happening for Medicare Advantage Plans. Thes...d may also include Part D Prescription Drug Covera...stant quotes and applications. , ... -- MediGap Advisors is pleased to announce open e...re Advantage Plans are health plan options that ar...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Substitutions Make Holiday Fare Healthier 2Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
...d out the increasing problem of super bugs to the ... farmlands. Super bugs are a new kind of microorga... affected by a wide range of antibiotics. The rese...ional Center and others who together had published...
...e treatment of osteoporosis is useful, but changes...tion. Nowadays the main treatment options are anti...r patients with previous fractures, treatment with...formation is preferable, and this is now possible ...
...July edition of the Journal of Neurosurgery sugges...everity of cases of constriction of blood vessels ...id haemorrhage (SAH). Normally constriction of b...following a SAH and this leads to strokes and neur...
...n chronic obstructive pulmonary disease (COPD) sai...en useful for patients of this disease to have imp...ructive pulmonary disease (COPD) are lung diseases...itions like lung tissue destruction, airway inflam...
Other Medicine News:Health News:The Benefits of Strontium in the treatment for Osteoporosis Questioned 2Health News:Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm 2
(Date:11/21/2008)... Nov. 21 Millions of Americans wit...are providers will soon have a new treatment optio...search & Development, L.L.C., (J&JPRD), an... (FDA) approved tapentadol immediate-release table... in adults 18 years of age or older. , , Ta...
(Date:11/21/2008)... Calif., Nov. 21 Amgen,...n Committee for Medicinal,Products for Human Use ...,marketing authorisation for Nplate(TM) (romiplost...nds Nplate for adult chronic immune (idiopathic),...ents who are refractory to,other treatments (e.g....
(Date:11/21/2008)...gland, November 21 , ... Committee for Medicinal Products for Human Use (C...for the approval of Enbrel(R),(etanercept) as a t...dolescents with severe plaque psoriasis. If approv...ittee,s recommendation, Enbrel will become the,fi...
(Date:11/21/2008)... Nov. 21 Ikaria Holdings, Inc. tod...y of the Year by the New Jersey Technology Council...at provides business support, networking opportuni...anies and their leaders. Ikaria earned the award b...nique product/service provision. , , "We ar...
Breaking Medicine Technology:FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 2FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 3FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 4FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 5FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 1Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 2Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 3Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves 16189 4Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 1Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 2Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 3Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 4Revolutionary CO2 maps zoom in on greenhouse gas sources 2797 5Consumer Reports 3A If Your Gums Could Speak 16180 1Consumer Reports 3A If Your Gums Could Speak 16180 2The PA Breast Cancer Coalition Participates in 2008 Patient Advocacy Leaders Summit 28PALS 29 3A PALs 28Patient Advocacy Leaders 29 for a Healthier 16175 1The PA Breast Cancer Coalition Participates in 2008 Patient Advocacy Leaders Summit 28PALS 29 3A PALs 28Patient Advocacy Leaders 29 for a Healthier 16175 2
...ta Presented at the American Academy of Neurology ...tion in Partial Seizures, BOSTON, May 01, 2007 /PR...ed today at the American Academy of Neurology (AAN...ly extended release,formulation of Lamictal(R) (la...ients with partial epilepsy with and without,secon...
...Study of over 7,700 women published today shows re...rcent in hip fractures, EAST HANOVER, N.J., May 02...Reclast(R) (zoledronic acid) Injection significant...tic bone fractures,over three years in women with ... today in The New England Journal of Medicine,mar...
Other Medicine Technology:New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 2New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 3New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 4New Data Shows Once a Day Lamictal XR is Effective in Treating,Patients with Partial Seizures 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 2Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 3Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 4Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 5Once-yearly Reclast Significantly Reduced Bone Fractures in Women,with Postmenopausal Osteoporosis 6
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband.
A rapid rise in intracranial pressure requires early recognition, intervention and continuous monitoring. Ventrix utilizes state-of-the-art fiberoptic technology that gets to the source of pressure.
The Codman ICP Monitoring System provides highly accurate measurements of intracranial pressure at the source-subdural, parenchymal or intraventricular levels. The information is relayed electronical
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)
Medicine Products: